Drug
ZL 1310
ZL 1310: highest development phase Phase 3, developed by Zai Lab. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Zai Lab
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZL-1310 NCT07218146 | Phase 3 | Small-cell Lung Cancer |
| ZL-1310 NCT06885281 | Phase 1/2 | Solid Tumors |
| ZL-1310 NCT06179069 | Phase 1 | SCLC |
Latest
Follow ZL 1310 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.